Meeting Coverage
SITC
Society for Immunotherapy of Cancer
Latest SITC Meeting Coverage
CTX130 yields sustained complete response in one patient with relapsed/refractory disease
November 15, 2022
Encouraging activity with antibiotic-free protocol but not with vancomycin preconditioning
November 14, 2022
Clinical benefit in more than a third of patients with anti-IL-8/nivolumab combo
November 13, 2020
Response rate of 20-30% with cemiplimab after post-hedgehog inhibitor progression or intolerance
November 11, 2020
Latest Oncology/Hematology Meeting Coverage
-
ASTRO: American Society for Radiation Oncology
October 2023
-
AVAHO: Association of VA Hematology/Oncology
September 2023
-
SOHO: Society of Hematologic Oncology
September 2023
-
AHNS: American Head & Neck Society
July 2023